LeMaitre Vascular (LMAT) Set to Announce Earnings on Thursday

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) will post its quarterly earnings results after the market closes on Thursday, October 31st. Analysts expect LeMaitre Vascular to post earnings of $0.44 per share for the quarter. Individual that wish to listen to the company's earnings conference call can do so using this link.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last released its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts' consensus estimates of $0.47 by $0.05. LeMaitre Vascular had a return on equity of 12.41% and a net margin of 18.33%. The business had revenue of $55.85 million during the quarter, compared to analyst estimates of $54.98 million. During the same quarter last year, the company posted $0.37 EPS. LeMaitre Vascular's revenue for the quarter was up 11.4% on a year-over-year basis. On average, analysts expect LeMaitre Vascular to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

LeMaitre Vascular Trading Down 0.4 %

LMAT stock traded down $0.39 during mid-day trading on Thursday, reaching $86.58. 96,665 shares of the stock traded hands, compared to its average volume of 121,922. The stock's fifty day moving average is $89.28 and its 200-day moving average is $82.00. The company has a market cap of $1.94 billion, a P/E ratio of 57.34, a P/E/G ratio of 2.45 and a beta of 0.88. LeMaitre Vascular has a 52-week low of $44.27 and a 52-week high of $93.32.

LeMaitre Vascular Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 29th. Investors of record on Thursday, August 15th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date was Thursday, August 15th. LeMaitre Vascular's dividend payout ratio is 42.38%.

Insider Activity at LeMaitre Vascular

In other LeMaitre Vascular news, Director David B. Roberts sold 3,063 shares of the stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $82.07, for a total transaction of $251,380.41. Following the transaction, the director now directly owns 14,114 shares of the company's stock, valued at $1,158,335.98. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 10.79% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several analysts have recently commented on LMAT shares. Cantor Fitzgerald started coverage on LeMaitre Vascular in a research report on Tuesday, October 15th. They issued a "neutral" rating and a $96.00 target price for the company. JMP Securities raised their price target on shares of LeMaitre Vascular from $77.00 to $100.00 and gave the stock a "market outperform" rating in a report on Tuesday, August 20th. Lake Street Capital assumed coverage on shares of LeMaitre Vascular in a research report on Friday, August 2nd. They issued a "buy" rating and a $105.00 target price for the company. StockNews.com downgraded shares of LeMaitre Vascular from a "buy" rating to a "hold" rating in a research note on Tuesday, August 27th. Finally, Barrington Research restated an "outperform" rating and issued a $92.00 target price on shares of LeMaitre Vascular in a research note on Friday, September 20th. Three equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $94.67.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.